Acute kidney injury is associated with an increased risk of developing dementia, according to a new study published in the journal Neurology by researchers at…
The pace at which the brain ages can vary significantly among individuals, leading to a gap between the estimated biological age of the brain and…
People with multiple sclerosis (MS) are far less likely than those without the condition to have the molecular hallmarks of Alzheimer’s disease, according to new…
Trinity researchers have examined the effectiveness of a new blood test which could change the way Alzheimer’s disease is identified. The blood test (plasma p-tau217)…
Dementia with Lewy bodies is a type of dementia that is similar to both Alzheimer’s disease and Parkinson’s disease, but studies on long-term treatments are…
A type of drug developed for treating cancer holds promise as a new treatment for neurodegenerative diseases such as Alzheimer’s, according to a study by…
The small molecule dopamine analog (DA) CA140, which binds to Amyloid-β (Aβ), presents new possibilities for the treatment of degenerative brain diseases.
Britain’s drug regulator authorized the Alzheimer’s drug Leqembi on Thursday, saying it’s the first medicine to show some impact in slowing the progression of the…
Researchers from the University of California, Irvine have discovered the neurons responsible for “item memory,” deepening our understanding of how the brain stores and retrieves…
Scientists on the team of Dr. Lenka Maletínská have developed a promising new compound derived from one of the peptides naturally occurring in the brain.…